fincash logo SOLUTIONS

Fincash » Search » Ipca Laboratories Ltd

Ipca Laboratories Ltd

Updated on August 2, 2020

Stock/Share Code - IPCALAB

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)

Below is the details of IPCALAB Ipca Laboratories Ltd

Market Cap₹18,885 Cr.
Current Price ₹1,956.7 as on 7 Aug 20
52 Week High / Low Price₹1,825 / ₹844.2
Face Value₹2
Stock P/E29.78
Book Value₹270.27
Dividend Yield0.33 %
ROCE16.53 %
ROE15.39 %
Sales Growth (3yrs)8.75 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free.
Cons: Stock is trading at 5.53 times its book value The company has delivered a poor growth of 2.19% over past five years. Company has a low return on equity of 10.94% for last 3 years.

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹180.85 28.53 ₹113,788.46 Cr. 0.63 ₹399.84 Cr. -2.03 14.25 8184.94 11.19
2. Dr Reddy's Labs ₹4,573.5 33.39 ₹67,652.81 Cr. 0.49 ₹781.1 Cr. 71.52 10.41 4448.90 12.42
3. Cipla ₹728.65 33.79 ₹52,256.4 Cr. 0.46 ₹245.95 Cr. -33.02 -0.63 4376.19 10.94
4. Aurobindo Pharma ₹906.45 16.67 ₹43,690.51 Cr. 0.40 ₹705.45 Cr. -2.26 11.87 5895.00 18.45
5. Biocon ₹399.45 62.53 ₹42,564 Cr. 0.14 ₹123.4 Cr. -42.26 3.41 1581.00 13.39
6. Torrent Pharma. ₹46.15 39.00 ₹39,979.07 Cr. 0.72 ₹314 Cr. 121.13 4.85 1946.00 12.66
7. Cadila Health. ₹390.9 25.02 ₹35,278.17 Cr. 1.02 ₹373.9 Cr. -26.54 1.68 3638.10 15.35
8. Ipca Labs. ₹141.9 29.78 ₹18,884.59 Cr. 0.33 ₹196.63 Cr. 22.76 20.21 1139.07 16.53

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ipca Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -6697138658607828549989488341,0111,2131,139
YOY Sales Growth %6.49%-16.53%-2.23%14.58%16.84%19.70%15.40%10.24%6.69%18.39%21.52%20.21%
Expenses -598691715698673740825716659816951874
Material Cost %34.66%37.51%34.12%34.19%32.75%32.52%31.40%31.63%32.26%35.86%33.78%33.49%
Employee Cost %23.73%24.48%21.65%21.21%21.57%22.88%20.42%18.60%21.21%20.33%18.12%19.11%
Operating Profit7122149162109114173232175195262265
OPM %11%3%17%19%14%13%17%24%21%19%22%23%
Other Income4611111314141315191418
Profit before tax26-211101237278141197141168227233
Tax %-73%5%12%14%28%16%15%19%23%21%14%16%
Net Profit44-20961065166120160109132196197
EPS in Rs3.52-1.607.648.374.075.199.4812.688.6710.4515.5115.56

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -1,0461,2671,5481,8812,3292,7783,2353,0882,8043,1023,1933,6064,196
Sales Growth %13.77%21.16%22.19%21.49%23.83%19.28%16.43%-4.54%-9.20%10.65%2.94%12.91%
Expenses -8861,1021,2391,4581,8652,2182,4992,5562,5282,6682,7482,9103,300
Material Cost %46.13%41.21%43.25%40.80%38.95%39.27%34.85%37.02%37.33%35.70%34.84%32.16%
Manufacturing Cost %7.44%7.23%6.30%6.63%7.35%10.45%7.94%9.53%9.83%9.24%9.40%8.88%
Employee Cost %13.76%14.54%13.98%13.91%13.83%13.55%14.77%17.53%21.52%21.76%22.32%20.86%
Other Cost %17.36%23.95%16.52%16.19%19.93%16.55%19.68%18.71%21.47%19.29%19.51%18.79%
Operating Profit160166309423464561736531276435445696897
OPM %15%13%20%22%20%20%23%17%10%14%14%19%21%
Other Income732441-2121921332821405566
Profit before tax177114272334369461629358111258283557769
Tax %20%20%23%23%24%28%24%28%17%27%18%18%
Net Profit1419120925528033147725693188233455634
EPS in Rs10.986.933.2519.7921.7425.6037.8320.297.3314.9218.4736.0050.19
Dividend Payout %14%30%17%16%14%15%13%5%0%7%5%8%

Compounded Sales Growth

  • 10 Years:: 11.02%
  • 5 Years:: 2.19%
  • 3 Years:: 8.75%
  • TTM:: 17.19%

Compounded Profit Growth

  • 10 Years:: 16.26%
  • 5 Years:: -1.16%
  • 3 Years:: 71.53%
  • TTM:: 59.84%

Return on Equity

  • 10 Years:: 18.45%
  • 5 Years:: 18.77%
  • 3 Years:: 43.82%
  • 1 Year:: 59.31%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital -25252525252525252525252525
Equity Capital25.0924.9925.0425.1425.1725.2425.2425.2425.2425.2425.2425.27
Other Liabilities -2152792933294675226416627567777858771,010
Trade Payables676569177233202265286401350376400540
Advance from Customers76565189220000
Other liability items141207219146229302366354355427409477470
Total Liabilities1,1761,3671,6221,9132,3302,7093,2173,8243,9053,9684,1084,4584,866
Fixed Assets -4135636366989131,0751,3061,7531,9771,9461,8551,7401,752
Gross Block5777648789861,2851,5251,8512,4662,1372,2772,3592,413
Accumulated Depreciation164201242288372450545713161331504673
Other Assets -6037318981,0721,2801,4821,7171,7221,7021,7161,9642,3292,634
Trade receivables264343392370345416449354441502594632865
Cash Equivalents86889556911316218131260252
Loans n Advances7385131196183187233219220263315331127
Other asset items-2-3-435799212811946605151268
Total Assets1,1761,3671,6221,9132,3302,7093,2173,8243,9053,9684,1084,4584,866

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -110155194215319387515455696271324487
Profit from operations186269337381521579763540313420468723
Loans Advances0000000-2729000
Operating borrowings5641243000000000
Direct taxes-29-22-45-64-80-92-130-74-29-54-57-108
Other operating items-1-1-100-379-12108-34-2139
Cash from Investing Activity --145-106-127-199-249-261-362-686-214-146-119-114
Fixed assets purchased-144-79-143-195-260-229-371-555-242-135-72-67
Fixed assets sold111111112212
Investments purchased-575-482-482-618-1,316-1,806-1,903-2,0380-2,100-2,456-2,614
Investments sold5704554916101,3161,8321,9062,04642,1072,4632,623
Subsidy received0000000000015
Investment income000000005000
Interest received366597132094015
Dividends received111011000000
Invest in subsidiaries-3-8-1-2-2-0-1-0-1000
Investment in group cos00000-1-7-220-30-15
Shares acq cancelled00000000001013
Acquisition of companies00000-670000-59-83
Other investing items000-120-0-1389-21-7-1
Cash from Financing Activity -37-51-64-17-69-81-138255-414-156-130-223
Proceeds from shares223210000005
Proceeds from debentures050005020000000
Redemption of debentures0000-17-330-55-5-5-50
Proceeds from borrowings891571961371106748815268610
Repayment of borrowings-15-48-69-42-157-97-111-110-517-196-182-195
Proceeds from deposits000000000000
Interest paid fin-17-29-29-29-37-34-28-31-28-23-22-17
Dividends paid-22-34-38-44-47-47-66-37-15-0-15-15
Other financing items0-7-30000000330
Net Cash Flow2-22-1145142568-3174150

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %24%16%25%26%24%24%27%13%4%9%9%17%
Debtor Days929992725455514257596864
Inventory Turnover4.254.534.624.514.143.984.123.523.213.643.663.74

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Ipca Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.